메뉴 건너뛰기




Volumn 949, Issue , 2001, Pages 292-294

SERMs, ethnicity, and clinical trials: Opportunities and challenges

Author keywords

Clinical trials; Ethnicity; SERMs

Indexed keywords

SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

EID: 0035683804     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb04035.x     Document Type: Conference Paper
Times cited : (5)

References (15)
  • 1
  • 3
    • 0030588699 scopus 로고    scopus 로고
    • Sex difference in risk of torsades de pointes with d,l-Sotalol
    • (1996) Circulation , vol.94 , pp. 2534-2541
    • Lehmann, M.H.1
  • 4
    • 0027515633 scopus 로고
    • Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs
    • (1992) JAMA , vol.270 , Issue.21 , pp. 2590-2597
    • Makkar, R.R.1
  • 8
    • 0032537396 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer: An overview of the randomised trials
    • (1998) Lancet , vol.351 , pp. 1451-1467
  • 12


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.